Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

OLIG2 antibody (AA 1-141)

The Mouse Monoclonal anti-OLIG2 antibody has been validated for IHC (f). It is suitable to detect OLIG2 in samples from Human.
Catalog No. ABIN6939031

Quick Overview for OLIG2 antibody (AA 1-141) (ABIN6939031)

Target

See all OLIG2 Antibodies
OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

Reactivity

  • 81
  • 44
  • 41
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 73
  • 23
  • 1
Mouse

Clonality

  • 64
  • 33
Monoclonal

Conjugate

  • 54
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This OLIG2 antibody is un-conjugated

Application

  • 53
  • 40
  • 35
  • 18
  • 15
  • 13
  • 13
  • 11
  • 11
  • 9
  • 8
  • 4
  • 3
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

OLIG2-2400
  • Binding Specificity

    • 16
    • 12
    • 9
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-141

    Specificity

    Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis).

    Cross-Reactivity (Details)

    Human,

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment of human OLIG2 protein (around aa 1-141) (exact sequence is proprietary)

    Isotype

    IgG1
  • Application Notes

    Positive Control: THP-1 cells. Astrocytoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.

    Expiry Date

    24 months
  • Target

    OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

    Alternative Name

    OLIG2

    Background

    Basic helix loop helix protein class B1 (bHLHB1), basic helix-loop-helix protein 19 (bHLHe19), OLIG2, Oligodendrocyte lineage transcription factor 2, Oligodendrocyte specific bHLH transcription factor 2, Oligodendrocyte transcription factor 2, Protein kinase C-binding protein 2 (PRKCBP2), RACK17,OLIG2 (Marker of Glial Brain Tumors)
    Cellular localisation: Nuclear

    Molecular Weight

    30-40kDa

    Gene ID

    10215, 176977

    UniProt

    Q13516
You are here:
Chat with us!